Bartlett, JMS

Dixon, JM

Evans, EE

Faratian, D

Harrison, DJ

Howell, AP

Katz, E

Langdon, SP

Larionov, A

MacLeod, K

Pedersen, H

Smith, EM

Breast Cancer Research

English

PubMed

Katz, E.

Faratian, D.

Bartlett, J. M. S.

MacLeod, K.

Pedersen, H.

Larionov, A.

Smith, E. M.

Howell, A. P.

Dixon, J. M.

Evans, E. E.

Langdon, S. P.

Harrison, D. J.

University of St Andrews Research Portal

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

St Andrews Research Repository

University of St. Andrews - Pure

Edinburgh Research Explorer

Cellular functions of the BRCA tumour-suppressor proteins. Biochem Soc Trans

Efficient deletion of normal Brca2-deficient intestinal epithelium by PARP inhibition models potential prophylactic therapy. Cancer Res

et al.: Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose)polymerase. Nature

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature

https://research-portal.st-andrews.ac.uk/en/researchoutput/c35-overexpression-defines-subsets-of-human-breast-cancer-and-its-immunoreceptor-tyrosinebased-activation-motif-represents-a-novel-treatment-target(642e9863-0bc0-4e88-a69b-d09661bb0d05).html

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

Abstract

Similar works

Full text

Available Versions

University of St Andrews Research Portal

St Andrews Research Repository

University of St. Andrews - Pure

University of St. Andrews - Pure

Edinburgh Research Explorer

Edinburgh Research Explorer